Vol. I · Iss. 04 · The consensus wireWed, Jul 08 · 21:04 EDT● LIVE
← All insiders
Insider record · § Co-CEO,

10% Zanganeh Mahkam insider buys

Every disclosed SEC Form 4 open-market purchase by 10% Zanganeh Mahkam (Co-CEO, · SMMT), with the stock's move after each filing. Disclosures are public record; returns are informational, not investment advice.

Disclosed buys
2
Total bought
$51.4M
Avg Δ7d
−2.0%
Win rate · 7d
50%
Avg Δ30d
+5.7%
Last filing
2026-06-12

Buy history

FiledTickerCompanyValuePrice @Δ1dΔ7dΔ30d
2026-06-12SMMTSummit Therapeutics Inc.$50.0M$13.08+8.0%+9.2%
2026-06-04SMMTSummit Therapeutics Inc.$1.5M$15.07−2.0%−13.2%+5.7%
Get alerts when insiders buy → Sign up free